Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
(Q52242595)
scientific article published in May 1998
scientific article published in May 1998
Language: